Intellectual Property India Publishes Patent Application for 'Methods Of Making Fusion Polypeptides' Filed by Ankyra Therapeutics, Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202527052588 A) filed by Ankyra Therapeutics, Inc., Cambridge, U.S.A., on May 30, for 'methods of making fusion polypeptides.'

Inventor(s) include Schmidt, Michael; Zarbis-Papastoitsis, Grigorios; and Mcneil, Gary.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides surprisingly useful methods of making fusion polypeptides including an immunomodulatory moiety and a metal-hydroxide binding moiety, as well as various related technologies, including and methods of making fusion polypeptides metal-hydroxide complexes and of using such fusion polypeptides and or/ fusion polypeptides metal-hydroxide complexes."

The patent application was internationally filed on Nov. 08, 2023, under International application No.PCT/US2023/037011.

Disclaimer: Curated by HT Syndication.